These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10760366)

  • 1. Inhibition of recombinant low-voltage-activated Ca(2+) channels by the neuroprotective agent BW619C89 (Sipatrigine).
    McNaughton NC; Hainsworth AH; Green PJ; Randall AD
    Neuropharmacology; 2000 Apr; 39(7):1247-53. PubMed ID: 10760366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human N-type voltage-gated Ca2+ channels by the neuroprotective agent BW619C89.
    McNaughton NC; Leach MJ; Hainsworth AH; Randall AD
    Neuropharmacology; 1997; 36(11-12):1795-8. PubMed ID: 9517454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects.
    Calabresi P; Stefani A; Marfia GA; Hainsworth AH; Centonze D; Saulle E; Spadoni F; Leach MJ; Giacomini P; Bernardi G
    Exp Neurol; 2000 Mar; 162(1):171-9. PubMed ID: 10716897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of a recombinant low voltage-activated Ca(2+) channel by SB-209712.
    McNaughton NC; Warre R; Cooper DG; Nasir S; Ranson JL; Randall A
    Eur J Pharmacol; 2000 Oct; 407(1-2):53-60. PubMed ID: 11050290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents.
    Hainsworth AH; McNaughton NC; Pereverzev A; Schneider T; Randall AD
    Eur J Pharmacol; 2003 Apr; 467(1-3):77-80. PubMed ID: 12706458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels.
    Shcheglovitov A; Zhelay T; Vitko Y; Osipenko V; Perez-Reyes E; Kostyuk P; Shuba Y
    Biochem Pharmacol; 2005 Mar; 69(5):841-54. PubMed ID: 15710361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.
    Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S
    Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential interactions of Na+ channel toxins with T-type Ca2+ channels.
    Sun H; Varela D; Chartier D; Ruben PC; Nattel S; Zamponi GW; Leblanc N
    J Gen Physiol; 2008 Jul; 132(1):101-13. PubMed ID: 18591418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92.
    Caputi L; Hainsworth AH; Lavaroni F; Leach MJ; McNaughton NC; Mercuri NB; Randall AD; Spadoni F; Swan JH; Stefani A
    Brain Res; 2001 Nov; 919(2):259-68. PubMed ID: 11701138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation properties of human recombinant class E calcium channels.
    Jouvenceau A; Giovannini F; Bath CP; Trotman E; Sher E
    J Neurophysiol; 2000 Feb; 83(2):671-84. PubMed ID: 10669483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK.
    Meadows HJ; Chapman CG; Duckworth DM; Kelsell RE; Murdock PR; Nasir S; Rennie G; Randall AD
    Brain Res; 2001 Feb; 892(1):94-101. PubMed ID: 11172753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.
    Todorovic SM; Jevtovic-Todorovic V; Mennerick S; Perez-Reyes E; Zorumski CF
    Mol Pharmacol; 2001 Sep; 60(3):603-10. PubMed ID: 11502893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
    Gomora JC; Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-dependent inhibition of Na+ currents by the neuroprotective agent 619C89 in rat hippocampal neurons and in a mammalian cell line expressing rat brain type IIA Na+ channels.
    Xie XM; Garthwaite J
    Neuroscience; 1996 Aug; 73(4):951-62. PubMed ID: 8809814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence.
    Callaway JK; Castillo-Melendez M; Giardina SF; Krstew EK; Beart PM; Jarrott B
    Neuropharmacology; 2004 Jul; 47(1):146-55. PubMed ID: 15165842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate.
    Goldin SM; Subbarao K; Sharma R; Knapp AG; Fischer JB; Daly D; Durant GJ; Reddy NL; Hu LY; Magar S
    Ann N Y Acad Sci; 1995 Sep; 765():210-29. PubMed ID: 7486608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib-mesylate blocks recombinant T-type calcium channels expressed in human embryonic kidney-293 cells by a protein tyrosine kinase-independent mechanism.
    Cataldi M; Gaudino A; Lariccia V; Russo M; Amoroso S; di Renzo G; Annunziato L
    J Pharmacol Exp Ther; 2004 Apr; 309(1):208-15. PubMed ID: 14718589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H.
    Lee JH; Gomora JC; Cribbs LL; Perez-Reyes E
    Biophys J; 1999 Dec; 77(6):3034-42. PubMed ID: 10585925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels.
    Singh A; Hildebrand ME; Garcia E; Snutch TP
    Br J Pharmacol; 2010 Jul; 160(6):1464-75. PubMed ID: 20590636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niflumic acid blocks native and recombinant T-type channels.
    Balderas E; Ateaga-Tlecuitl R; Rivera M; Gomora JC; Darszon A
    J Cell Physiol; 2012 Jun; 227(6):2542-55. PubMed ID: 21898399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.